Active Cycle of Breathing Techniques on Respiratory Distress Symptom Cluster

NCT ID: NCT05879354

Last Updated: 2025-06-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

78 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-10-01

Study Completion Date

2024-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study was designed as a randomized, control group, experimental study to examine the effect of Active Cycle of Breathing Techniques application on respiratory distress symptom cluster in patients with lung cancer.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The sample of the study will consist of patients who received chemotherapy treatment with the diagnosis of Stage IV non-small cell lung cancer in the outpatient chemotherapy service of a training and research hospital and met the inclusion criteria. Data in the study will be collected using the Patient Information Form, Eastern Cooperative Oncology Group (ECOG) Performance Scale, Cancer Dyspnea Scale, Leicester Cough Questionnaire and Cancer Fatigue Scale. In order to test the applicability and comprehensibility of the forms to be used before the study, a preliminary application will be made with 5 patients. This study is planned to prepare a video describing the application for patients to use while performing the Active Cycle of Breathing Techniques application. On the 1st day of the study, a 10-minute face-to-face training will be given to the intervention (experimental) group by the researcher using the video about the Active Cycle of Breathing Techniques. In the research, the intervention (experimental) group will be asked to follow the video to be prepared and apply the Active Cycle of Breathing Techniques twice a day for 28 days. The intervention (experimental) group will be monitored by telephone call once a week and 3 times using the Patient Follow-up Form (days 7, 14 and 21). On the other hand, only the pre-test and post-test will be applied to the control group.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lung Neoplasms

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

The intervention group will apply the Active Cycle of Breathing Techniques with video twice a day for 28 days and the control group will not.
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Active Cycle Of Breathing Techniques Group

Patients in the intervention group will be provided with video-guided Active Cycle of Breathing Techniques twice a day for 28 days.

Group Type EXPERIMENTAL

Active Cycle of Breathing Techniques

Intervention Type OTHER

Patients in the intervention group will be provided with video-guided Active Cycle of Breathing Techniques twice a day for 28 days.

Control group

No intervention will be given to the patients in the control group.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Active Cycle of Breathing Techniques

Patients in the intervention group will be provided with video-guided Active Cycle of Breathing Techniques twice a day for 28 days.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Being 18 years or older
* Being diagnosed with stage IV non-small cell lung cancer
* Being diagnosed with lung cancer in the type of adenocarcinoma and squamous cell carcinoma
* Receiving outpatient chemotherapy treatment
* Receiving the first course of chemotherapy treatment
* ECOG Performance Scale Score \< 3
* Having all the symptoms of dyspnea, cough, and fatigue
* Not having a cognitive disorder or a diagnosed psychiatric illness
* Being able to speak Turkish
* Volunteering to participate in the research

Exclusion Criteria

* Experiencing a chronic obstructive pulmonary disease (COPD) exacerbation in the last 4 weeks
* Having an active lung infection
* Not volunteering to participate in the research
* Not having dyspnea, cough, and fatigue symptoms
* Not speaking Turkish
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Saglik Bilimleri Universitesi

OTHER

Sponsor Role collaborator

Maltepe University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Doğa Ulcay

Lecturer

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Doğa Ulcay, Msc

Role: PRINCIPAL_INVESTIGATOR

Maltepe University

Semiha Akın, Prof.

Role: PRINCIPAL_INVESTIGATOR

University of Health science

Akın Öztürk, Specialist

Role: PRINCIPAL_INVESTIGATOR

Süreyyapaşa Chest Diseases and Thoracic Surgery Training And Research Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Süreyyapaşa Chest Diseases and Thoracic Surgery Training and Research Hospital

Istanbul, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MAU_DogaUlcay_001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Acupressure for Cough in Lung Cancer Survivors
NCT07315672 NOT_YET_RECRUITING NA